|
|
 |
|
Programme of the Conference
The scientific programme will consist of keynote lectures, and free oral and poster presentations.
EuroNanOSH | Instructions for contributors | Registration and Payment | General Information |Contact |Photo Gallery
Scientific Programme (Final 3 December 2007)
Please check the final programme in late November for possible changes.
Sunday, 2 December 2007
16.30–19.00 Registration and information desk open at the loppy of the hotel Grand Marina Scandic (Address: Katajanokanlaituri 7, Helsinki)
18.30–20.00 Get-together at hotel Grand Marina Scandic, Commodore room
(Address: Katajanokanlaituri 7, Helsinki)
Monday, 3 December 2007
08.00–17.00 Registration and information desk open
Opening
Place: Fennia II
Chair: Harri Vainio, Finland
9.00
Opening address
Representative of Finnish Government
Address of the European Commission
Dr Pilar Aguar, Research Programme Officer, Directorate-General for Research, European Commission
Address of the European Chemical Agency (ECHA)
Dr Geert Dancet, Executive Director of ECHA, European Commission
Address of the Organization for Economic Co-operation and Development (OECD)
Mar Gonzalez, Administrator Environment, Health and Safety Division, Environment Directorate, OECD
Address of the World Health Organization (WHO)
Dr Ivan Ivanov, Scientist, Department of Public Health and Environment, WHO
Address of ISPESL – National Institute for Occupational Safety and Prevention, Italy
Professor Antonio Moccaldi, President of ISPESL – National Institute for Occupational Safety and Prevention, Italy
10.30–11.00 Coffee/tea break
Opening keynote
Place: Fennia II
Chair: Harri Vainio, Finland
11.00–12.00
Emerging global safety issues of nanotechnologies – Future challenges
Andrew Maynard, Woodrow Wilson International Centre for Scholars, USA
12.00–13.30 Lunch
Plenary I:
Tackling with the safety of nanotechnologies today – National and global approaches
Venue: Fennia II
Chairs: Sergio Iavicoli, Italy and Ruth Duncan, United Kingdom
13.30–14.00
Global approaches and possible solutions to face nanotechnology safety challenges
Ruth Duncan, Cardiff University, United Kingdom
14.00–14.30
Tackling with future nanotechnology challenges in Europe
Pilar Aguar, Directorate General for Research, European Commission
14.30–15.00
Research strategy on safety of nanotechnologies in Japan - Introduction of NEDO project (2006-2010) entitled ‘Evaluating Risks Associated with Manufactured Nanomaterials’
Toshihiko Myojo, University of Occupational and Environmental Health, Japan
15.00–15.30 Coffee/tea break
15.30–16.00
Current occupational safety and health issues of nanotechnology in USA
Paul Schulte, National Institute for Occupational Safety and Health, USA
16.00–16.30
Promotion of safety of nanotechnologies in Finland jointly with the industry – Progress and challenges
Tuomas Raivio, Gaia Consulting Oy, Finland
16.30–17.00
Estimating occupational exposure to nanoparticles: Gaps and needs
Sergio Iavicoli, ISPESL– National Institute for Occupational Safety and Prevention, Italy
17.00 End of first day programme
19.00–20.30 Helsinki City Reception at Helsinki city Hall (Address: Pohjoisesplanadi 11-13, Helsinki)
Host: Mrs Paula Kokkonen, Deputy Mayor for Social Affairs and Public Health, City of Helsinki
http://www.hel.fi
Tuesday, 4 December 2007
8.00–17.00 Registration and information desk open
Plenary II:
Tackling with the scientific challenges of nanotechnology to solve workplace hazards
Place: Fennia II
Chairs: Anna A Shvedova, USA, and Kaarle Hämeri, Finland
9.00–9.30
Efforts by the Japanese National Institute of Health Science to develop measures to evaluate the health effects of manufactured nanomaterials
Akihiko Hirose, National Institute of Health Science, Japan
9.30–10.00
Occupational exposure to nanoparticles and risks associated with nanotechnology in the workplace
Vincent Castranova, National Institute for Occupational Safety and Health, USA
10.00–10.30
Carbon NanoBuds (CNBTM) and Single Walled NanoTubes (SWCNT) – Synthesis, structure and properties
Esko I. Kauppinen, Nanomaterials Group, Laboratory of Physics & Center for New Materials, Helsinki University of Technology & VTT Biotechnologyy, Finland
10.30–11.00
Facing the key workplace challenge: Assessing and preventing exposure to nanoparticles at source
Kaarle Hämeri, Finnish Institute of Occupational Health, Finland
11.00–11.30 Coffee/tea break
11.30–12.0
Toxicity of single walled carbon nanotubes in vivo:
Relevance to occupational exposures
Anna A Shvedova, National Institute for Occupational Safety and Health, USA
12.00–12.30
Brain and Heart: Key targets of nanoparticles?
Wolfgang Kreyling, GSF - National Research Center for Environment and Health, Germany
12.30–13.30 Lunch
13.30–14.30 Poster session
Venue: Nordia
- In vitro assessment of genotoxicity of Co nanoparticles and ions: Influence of chemistry and of biological variability on genotoxic endpoints
Colognato R, Bergamaschi E, Bonelli A, Farina M, Sabbioni E, Migliore L, Italy
- A novel and simple dispersing technique for carbon nanotubes that can be used for in vivo and in vitro studies
Elgrabli D, Abella-Gallart S, Aguerre-Charriol O, Robidel F, Rogerieux F, Boczkowski J, Lacroix G, France
- Genotoxicity of titanium dioxide in vitro
Falck GC-M, Lindberg HK, Suhonen S, Vippola M, Vanhala E, Savolainen K, Norppa H, Finland
- Personal exposure of a tile worker to nanopollution and contamination of his partner: A case report
Gatti AM, Gambarelli A, Montanari S, Ferri C, Giuggioli D, Italy
- Industrial and environmental not-engineered nanopollution and its impact on human health
Gatti AM, Gambarelli A, Montanari S, Italy
- Cross sectional study on respiratory effect of toner exposed work in manufacturing plants, Japan – Pulmonary function, blood cells and biochemical markers
Kitamura H, Terunuma N, Kurosaki S, Hata K, Kuga H, Kakiuchi N, Masuda M, Yoshizumi K, Morimoto Y, Kasai H, Higashi T, Murase T, Japan
- Respiratory morbidity and exposure to toner dust: A cross-sectional study on toner manufacturing and service workers in a Japanese company – Pulmonary functions, blood cells and biochemical markers
Matsushita T, Kuga T, Kitamura H, Terunuma N, Nakamoto K, Kakiuchi N, Kurosaki S, Hata K, Masuda M, Yoshizumi K, Higashi T, Japan
- Experimental set-up for inhalation exposure of mice to nanosized TiO2
Mäkinen M, Miettinen M, Jokiniemi J, Joutsensaari J, Korpi A, Pasanen P, Finland
- Regulatory implications of the research into and the risk assessment of nanomaterials
Orthen B, Germany
- Safety assessment of azelaic acid and its derivatives entrapped in nanovesicles
Panyosak A, Manosroi J, Rojanasakul Y, Manosroi A, Thailand
- Acute changes of cardiovascular autonomic regulation induced by single-wall carbon nanotubes in rats: An original experimental model
Pietroiusti A, Magrini A, Legramante J M, Palleschi G, Moscone D, Valentini F, Sacco S, Galante A, Bergamaschi E, Bottini M, Bergamaschi A, Italy
- Acute effects of aerosol exposure of titanium dioxide on airway inflamation in mice
Rossi E, Pylkkänen L, Nykäsenoja H, Wolff H, Alenius H, Savolainen K, Finland
- Cross sectional study on respiratory effect of toner exposed work in manufacturing plants, Japan – Subjective respiratory symptoms, incidence of respiratory disease using questionnaire and findings in chest roentgenogram
Terunuma N, Kitamura H, Kuga H, Kurosaki S, Kakiuchi N, Masuda M, Hata K, Yoshizumi K, Morimoto Y, Kasai H, Higashi T, Murase T, Japan
- Nanotechnology and Occupational Health in Russia
Tkach AV, Tkacheva TA, Russian Federation
- NANOKEM: Dust from nanoparticle-containing paints: Exposure assessment and toxicological properties
Vogel U, Schneider T, Jensen K A, Stoltenberg M, Hougaard KS, Larsen ST, Loft S, Möller P, Wallin H, Denmark
- Biogenic generated nano-sized particles in the ozone-limonene system: Bioassay testing and hydroxyl radical potential
Wolkoff P, Clausen PA, Nørgaard AW, Larsen K, Denmark
- Genotoxicity of nanosized titanium dioxide in human lymphocytes in vitro
Hannukainen K, Lindberg HK, Falck GC-M, Järventaus H, Vippola M, Vanhala E, Savolainen K, Norppa H, Finland
- Genotoxicity of carbon nanomaterials in vitro
Lindberg HK, Falck GC-M, Suhonen S, Vippola M, Vanhala E, Savolainen K, Norppa H, Finland
- Exploring the feasiblity to use a structured observational method to assess dermal exposure to engineered nanoparticles (ENPs): Results from NANOSH pilot studies
Brouwer D, Hertsenberg S, Moehlmann C, Berges M, Wake D, Mark D, the Netherlands
- Chemical and dimensional characterization of nanoparticles in the evaluation of professional exposure
Castellano P, Ferrante R, Canepari S, Astolfi M L, Italy
- Risk assessment model of occupational exposure to nanomaterials
Geraci D, Giacobbe F, Monica L, Italy
- Portable low cost airborne particle size distribution spectrometer for exposure/dose evaluation
Gnewuch HWJ, Gorbunov B, Muir RB, United Kingdom
- Emission of nanoparticles in the process of developing new polymers
Jankowska E, Zatorski W, Posniak M, Poland
- Characterizing surface-area of airborne nanostructured particles
Bau S, Witschger O, Gensdarmes F, Thomas D, France
- Measurement of particle characteristics at seven Swedish plants
Elihn K, Berg P, Sweden
- Determination of backbone chain directions of PDA using FFM
Jo S, Takenaga M, Japan
- Production and characterization of engineered titanium dioxide nanoparticles for in vitro and in vivo toxicity tests
Koivisto J, Alenius H, Hämeri K, Jokiniemi J, Joutsensaari J, Norppa H, Miettinen M, Pasanen P, Pylkkänen L, Rossi E, Tuomi T, Vippola M, Finland
- Synthesis of TiO2 nanoparticles for the studies of their health effects
Miettinen MA, Suonmaa V, Tapper U, Backman U, Joutsensaari J, Auvinen A, Jokiniemi J, Finland
- Volatile emissions from gas-phase oxidation of carbon nanotubes and fullerenes by ozone and nitrate radicals
Nøjgaard JK, Clausen PA, Wolkoff P, Denmark
- Effect of dispersing media on nanoparticles reactivity
Sauvain J-J, Deslarzes S, Riediker M, Switzerland
- Preparation of nanoparticle dispersions for genotoxicity testing
Vippola M, Falck G, Lindberg H, Suhonen S, Vanhala E, Norppa H, Tossavainen A, Tuomi T, Finland
- Nanoparticle characterization protocol for occupational exposure and health effects
Vippola M, Bard D, Burdett G, Vanhala E, Tuomi T, Mark D, Tossavainen A, Finland
- Information & training N@NORISK website
Sicard Y, Tardif C, Tardif F, France
- Guidence for handling and use of nanomaterials at the workplace
Heinemann M, Germany
FC session 1: Toxicity and health effects of nanoparticles
(theme continues after break, parallel to FC session 2)
Place: Fennia II
Chair: Antoinetta Gatti, Italy
14.30-14.45
Self-reported repiratory symptoms and exposure to toner dust: a cross sectional study on toner manufacturing and service workers in a Japanese company.
Kuga H, Matsushita T, Kitamura H, Terunuma N, Nakamoto K, Kakiuchi N, Kurosaki S, Hata K, Masuda M, Yoshizumi K, Higashi T, Japan
14.45-15.00
Effects of nano-sized titanium dioxide exposure on allergic asthma
Pylkkänen L, Rossi E, Leino M, Wolff H, Savolainen K, Alenius H, Finland
15.00-15.15
Carbon black and diesel exhaust particles are mutagenic in the FE1-Muta™Mouse lung epithelial cell line. Single-walled carbon nanotubes and fullerenes (C60) are not.
Jacobsen N R, Møller P, Saber A T, Cohn C, White P, Pojana G, Korsholm K, Vogel U, Loft S, Wallin H, Denmark
15.15-15.30
NanoImpactNet – European Network on the Health and Environmental Impact of Nanomaterials
Riediker M, Switzerland
15.30-16.00 Coffee/tea break
FC session 2: Exposure to and control of nanoparticles
(Parallel to FC session 1a)
Place: Fennia I
Chair: Timo Tuomi, Finland
14.30-14.45
NANOPLAST: Nano-technological materials and products in the plastics industry: Exposure assessment and toxicological properties
Clausen PA, Vogel U, Høg Lejre A-L, Bøgelund J, Jensen KA, Nørgaard AW, Nøjgaard JK, Schneider T, Cohn C, Saber AT, Møller P, Loft S, Wallin H, Wolkoff P, Denmark
14.45-15.00
Health risk, exposure and bioavailability of lead nanoparticles at working places
Gorbunov B, Muir R, Priest ND, Jackson P, United Kingdom
15.00-15.15
Aerosol Dynamics of NP in Workplace Exposure
Seipenbusch M, Binder A, Kasper G, Grimm H, Wu Q, Germany
15.15-15.30
Experimental evaluation of individual devices against nanoaerosols: fibrous filter media, cartridge for respirators, protective clothing and gloves
Bernard ST, Tardif F, Rouillon F, Guiot A, Golanski L, France
15.30-16.00 Coffee/tea break
FC session 1b: Toxicity and health effects of nanoparticles
(theme continues from before break, parallel to FC session 3)
Place: Fennia II
Chair: Harri Alenius, Finland
16.00-16.15
Toxicity of Nanoparticles versus 3T3 cells
Gatti A M, Sighinolfi G, Quaglino D, Tossini D, Italy
16.15-16.30
Impact of physico-chemical characteristics on in vitro toxicity of oxide nanoparticles and carbon nanotubes
Simon A, Reynaud C, Mayne M, Herlin N, Desqueroux H, Gouget B, Carriere M, France
16.30-16.45
Carbon nanotubes affect the barrier function of human epithelial cells in vitro
Bergamaschi E, Rotoli BM, Bianchi MG, Bellucci S, Magrini A , Bussolati O, Italy
16.45-17.00
Genotoxic effects of nanomaterials
Norppa H, Falck GC-M, Lindberg HK, Suhonen S, Savolainen K, Finland
FC session 3: Nanoparticle chracteristicsc
(Parallel to FC session 1b)
Place: Fennia I
Chair: Pertti Pasanen, Finland
16.00-16.15
An alternative method to BET method for estimating off-line the specific surface area of nanostructured particles
Bau S, Witschger O, Gensdarmes F, Thomas D, Rastoix O, France
16.15-16.30
Metal and metal oxide nanoparticle generation by liquid flame spray for instrument testing and exposure studies
Mäkelä JM, Aromaa M, Keskinen H, Rostedt A, Marjamäki M, Keskinen J, Finland
16.30-16.45
Selection of metrics relevant for inhalation health risk study of nanoparticle aerosols
Wu Q, Seipenbusch M, Kasper G, Grimm H, Weitzenböck J, Norway
16.45-17.00
Nanoparticle Monitor Based on Escaping-Current Technology (ECT)
Janka K, Ukkonen A, Nokkonen E, Reinivaara R, Niemelä V, Finland
approx. 19.00 Busses from hotel to the dinner (please, check final programme)
19.30–22.00 Conference dinner at Restaurant Pörssi, Helsinki (Address: Fabianinkatu 14, Helsinki)
Wednesday, 5 December 2007
8.00–15.00 Registration and information desk open
Plenary III:
Risk management and control technology
Place: Fennia II
Chairs: Kai Savolainen, Finland and Ellen Silbergeld, United States
9.00–9.30
Nanomaterial health effects research contributes to risk management strategies through the risk assessment paradigm
Kevin Dreher, Pulmonary Toxicology Branch, Environmental Protection Agency, USA
9.30–10.00
Looking as we leap: Prudent risk assessment for nanotechnologies
Ellen Silbergeld, Johns Hopkins University, Bloomberg School of Public Health, USA
10.00–10.30
Control technologies to prevent exposure to nanoparticles
Markus Berges, BG- Institute for Occupational Safety and Health, Germany
10.30–11.00
Managing nanotechnology risks to workers: Integration of health and safety into the workplace
Dave Mark, Health and Safety Laboratory, United Kingdom
11.00–11.30 Coffee/tea break
11.30–12.00
Metal and mataloxide nanoparticles and their properties in workplace air
Jorma Jokiniemi, VTT Technical Research Centre of Finland, Finland
12.00–12.30
Assessing inhalation exposure to nanoaerosols in the workplace
Olivier Witschger, Laboratoire de Métrologie des Aérosols, INRS - Centre de Lorraine, France
12.30–13.00
Integrating safety into nanomaterial production – Key to success
Jacques Ragot, Bayer MaterialScience AG, Germany
13.00–13.30 CANCELLED
Risk communication with regard to nanotechnology and nanomaterials
Virginia Sublet, National Institute for Occupational Safety and Health, United States
Closing
13.30–13.45 Rescheduled to 13.00
Conclusions and closing
Kai Savolainen, Finnish Institute of Occupational Health, Finland
13.45–15.00 Lunch
|
|
|
|